There are four classes of anti-infectives used for BRD treatment. It is impotant to use the correct class of antibiotic to ...
Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...
Pipeline of antibiotics under development is shrinking putting children at risk amid global drug resistance crisis, report finds.
Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.
Five years after the release of its previous Antimicrobial Resistance (AMR) Benchmark, the Access to Medicine Foundation has identified ...
Peptilogics' PLG0206 is a first-in-class anti-biofilm drug candidate being studied in patients with prosthetic joint ...
Antibiotic production from big pharmaceutical companies has slowed significantly in the last five years, leaving children in low- and middle-income countries particularly exposed to hard-to-treat ...
A new report from the Centers for Disease Control and Prevention on the deadly drug-resistant bacteria NDM-CRE found a 70% rise in infections in the U.S. between 2019 and 2023. Also known as ...
A case series reports dysesthesia and allodynia in patients treated with semaglutide and tirzepatide, suggesting a possible dose related to sensory adverse effect.
The Print on MSN
Study links heavy metals, ‘hidden drugs’ in alt meds to liver injury. Safety, regulation debate grows
Kerala researchers study 386 products, covering Ayurveda, Homoeopathy, Siddha, Unani, other traditional remedies. Findings raise concerns about regulatory oversight of Ayush meds.
Alembic Pharmaceuticals Limited has reported the first prescription-based sale of its branded antibiotic Pivya (pivmecillinam ...
Report Highlights the Company's Collaboration with GARDP to Develop NUZOLVENCE (R) (zoliflodacin) for Oral Suspension for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results